Who Discovered Salmonella? The True Story

The genus Salmonella is named after Daniel Elmer Salmon, an American veterinary pathologist who headed the United States Bureau of Animal Industry in the 1880s. But the bacterium was actually isolated in the laboratory by Theobald Smith, a young researcher working under Salmon’s direction. The story of how Salmon’s name ended up on one of the most consequential pathogens in history, while Smith’s pivotal role faded into the background, is one of the more instructive episodes in the politics of scientific credit.

The Bureau of Animal Industry and the Hog Cholera Hunt

In 1884, Daniel Elmer Salmon became the first person in the United States to receive a Doctor of Veterinary Medicine degree and was appointed to lead the newly created Bureau of Animal Industry within the U.S. Department of Agriculture. The bureau’s urgent mission was to tackle diseases devastating American livestock, and hog cholera was near the top of the list. It was killing pigs in enormous numbers, and nobody knew exactly what caused it.

Salmon hired Theobald Smith, then a fresh medical school graduate with a keen interest in laboratory science, to do the hands-on investigative work. Smith was only 25 years old when he joined the bureau, but he quickly proved to be a gifted experimentalist. Working with cultures from diseased pigs, Smith isolated the rod-shaped bacterium that would later bear his boss’s name. He grew it, characterized it, and showed it could cause disease when introduced into healthy animals.

There is an irony built into the story from the start. The organism Smith isolated from hog cholera cases turned out not to be the true cause of hog cholera at all. The actual culprit was later identified as a virus. But the bacterium Smith found was real, pathogenic, and enormously important in its own right. It became the founding member of the genus Salmonella.

Who Deserved the Credit

In 1886, Salmon and Smith jointly published their landmark work describing an experimental vaccine made from heat-killed hog cholera bacteria. They showed that injecting these dead bacteria into pigeons protected the birds against subsequent challenge with live, virulent organisms. It was one of the earliest demonstrations that killed microbes could generate protective immunity, a concept that would reshape vaccine science.

But the authorship dynamics were not what they appeared. Salmon, as head of the bureau, routinely listed himself as first author on publications that came out of his laboratory, regardless of who had done the benchwork. Smith grew increasingly frustrated as he watched Salmon claim credit not just on the hog cholera papers but across multiple lines of research Smith had conducted largely on his own. Salmon also elevated the contributions of F. L. Kilborne, the superintendent of the bureau’s experimental farm, making him coauthor on the landmark Texas cattle fever monograph that Smith had driven from hypothesis to proof. Smith eventually left the bureau, weary of what he saw as repeated injustices.

Smith went on to a distinguished career at Harvard and later at the Rockefeller Institute, producing groundbreaking work on Texas cattle fever (proving for the first time that an arthropod could transmit disease), tuberculosis, and anaphylaxis. Many historians of science regard him as the most accomplished American microbiologist of his generation. Yet the genus name Salmonella, proposed by the French bacteriologist Joseph Lignières in 1900, honored Salmon rather than Smith. Lignières chose the name based on the published record, where Salmon’s name appeared first.

The Killed-Vaccine Breakthrough

Whatever the credit dispute, the scientific contribution was genuine and far-reaching. The 1886 Salmon-Smith publication demonstrated that heat-killed bacteria could provoke a protective immune response, a finding that arrived just a few years after Pasteur’s pioneering work with attenuated (weakened) live vaccines for anthrax and rabies. The killed-vaccine approach opened a fundamentally different path: instead of weakening a pathogen and hoping it stayed weak, you could destroy it entirely and still train the immune system to recognize it.

This principle became the foundation for an entire class of vaccines. Within a decade, killed whole-cell vaccines were being developed for typhoid fever, cholera, and plague. The Salmon-Smith experiment using heat-killed salmonella in pigeons is recognized as the first demonstration of this approach.

1Comparative Immunology, Microbiology and Infectious Diseases. A brief history of the prevention of infectious diseases by immunisations

From One Bacterium to Thousands of Serovars

Smith’s original isolate was just the tip of an enormous iceberg. As microbiologists around the world began culturing bacteria from sick people and animals, they kept finding organisms that looked similar but behaved differently. Some caused gastroenteritis. Some caused typhoid fever. Some seemed to prefer poultry, others pigs, others humans exclusively. The question of how to organize this sprawling family became one of microbiology’s great classification puzzles.

The first systematic attempt at sorting Salmonella strains by their surface markers came from Philip Bruce White and colleagues in 1924. But it was Fritz Kauffmann, a Danish microbiologist, who turned this into a comprehensive system. Working at the Statens Serum Institut in Copenhagen, Kauffmann developed a classification scheme based on three types of antigens found on the bacterial surface and flagella. He published his antigenic scheme in 1930, and by 1934 it had been formally adopted, containing 44 validated serovars. By the time Kauffmann retired in 1965, the scheme had grown to include 958 serovars.

2PubMed Central. Fritz Kauffmann: innovator in microbial classification

Today the count exceeds 2,600 serovars, and the Kauffmann-White scheme (now called the Kauffmann-White-Le Minor scheme after later contributors) remains the standard reference. Each serovar has a unique combination of surface antigens, which is why public health laboratories can pinpoint whether an outbreak involves Salmonella Typhimurium, Salmonella Enteritidis, Salmonella Typhi, or any of the other named variants. The naming system Kauffmann built still underpins modern outbreak investigations worldwide.

Typhoidal Versus Non-Typhoidal Disease

One of the most consequential distinctions within the genus is between typhoidal and non-typhoidal serovars. Non-typhoidal Salmonella causes the food poisoning most people associate with the name: nausea, diarrhea, abdominal cramps, and fever that typically resolve on their own in healthy adults. Typhoidal Salmonella, by contrast, causes typhoid fever, a systemic infection with a mortality rate of up to 30% if left untreated.

3PubMed Central. One species, different diseases: the unique molecular mechanisms that underlie the pathogenesis of typhoidal Salmonella infections

The difference lies in how the two types interact with the human gut. Both typhoidal and non-typhoidal serovars initially invade the lining of the small intestine. But non-typhoidal strains trigger a strong inflammatory response, recruiting waves of immune cells that largely contain the infection locally. The result is intense but self-limiting gastroenteritis. Typhoidal serovars, on the other hand, slip through the intestinal lining with minimal inflammation, which allows them to reach the lymph nodes, liver, spleen, and bone marrow. From there, they can cycle back to the gut through bile, restarting the process.

4PubMed Central. Same species, different diseases: how and why typhoidal and non-typhoidal Salmonella enterica serovars differ

Typhoidal Salmonella is also unusual in being restricted to humans. Most non-typhoidal serovars happily infect chickens, pigs, cattle, reptiles, and people alike. Salmonella Typhi and Salmonella Paratyphi evolved to specialize in human hosts, which is why typhoid fever spreads through contaminated water and food in areas with poor sanitation rather than through contact with animals.

Mary Mallon and the Carrier Problem

The concept of a healthy carrier, someone who harbors and spreads a pathogen without ever showing symptoms, was one of the most unsettling discoveries in the history of infectious disease. In 1907, sanitary engineer George Soper traced a string of typhoid fever outbreaks in New York City to a cook named Mary Mallon. She had no symptoms herself but was shedding Salmonella Typhi and transmitting disease through the food she prepared. Soper became the first to describe a healthy carrier of Salmonella Typhi in the United States.

5PubMed Central. Mary Mallon (1869-1938) and the history of typhoid fever

Mallon, who became known as “Typhoid Mary,” was eventually quarantined, released on the promise she would stop cooking, broke that promise, caused more outbreaks, and was quarantined again for the rest of her life. Her case raised questions that remain relevant: what rights does a healthy carrier have? When does public health override personal freedom? These were not abstract debates. Mallon spent nearly three decades in forced isolation on North Brother Island in New York’s East River.

The carrier state also posed a practical diagnostic challenge. How do you identify someone shedding bacteria when they feel perfectly fine? This question drove the development of serological tests and stool cultures that remain cornerstones of typhoid surveillance.

The Widal Test and a Century of Diagnostic Debate

In 1896, French physician Georges-Fernand Widal introduced a blood test for typhoid fever based on the principle that a patient’s serum would clump (agglutinate) typhoid bacteria if the patient had been infected. The Widal test was a landmark in diagnostic medicine, one of the earliest serological tests for any infectious disease. But more than a century later, it remains surprisingly controversial.

The test has persistent problems with both the quality of the antigens used and the interpretation of results, particularly in regions where typhoid is common. In areas where many people have been exposed to Salmonella Typhi or have received typhoid vaccines, background antibody levels can be high enough to produce misleading positive results. Conversely, early in infection, antibody levels may not yet be high enough to trigger a positive test.

6PubMed Central. Widal agglutination test − 100 years later: still plagued by controversy

Despite these limitations, the Widal test persists in clinical use across much of the developing world because it is cheap, fast, and requires minimal laboratory infrastructure. More accurate methods, including blood cultures and molecular tests, exist but are often impractical in the resource-limited settings where typhoid remains most common. The test Widal introduced in 1896 is, for better or worse, still the front-line diagnostic tool in many parts of the world.

Antibiotic Resistance and the Modern Threat

Salmonella’s story has taken a worrying turn in recent decades. Multidrug-resistant strains have become increasingly common, driven largely by the widespread use of antibiotics in livestock production. Animal-origin foods, including meat, eggs, and dairy, serve as important vehicles for transmitting resistant organisms and resistance genes to humans.

7PubMed Central. Antimicrobial resistance in foodborne Escherichia coli and Salmonella spp. from animal-origin foods: Transmission pathways, global surveillance gaps, and alternative therapeutic strategies

A particularly striking example is Salmonella 4,[5],12:i:-, a monophasic variant of the well-known Salmonella Typhimurium serovar. This strain has emerged as a global cause of multidrug-resistant salmonellosis, spreading rapidly across multiple continents.

8Nature Communications. Evolutionary dynamics of multidrug resistant Salmonella enterica serovar 4,[5],12:i:- in Australia

The resistance profiles are sobering. In studies of Salmonella isolates from poultry and swine production chains, roughly two-thirds of isolates showed resistance to ampicillin, over half to tetracycline, and more than 40% to ciprofloxacin, a fluoroquinolone antibiotic considered critical for treating severe salmonellosis in humans. Whole-genome sequencing of these strains has revealed widespread carriage of resistance genes and enhanced biofilm formation, meaning resistant strains may also be better at persisting in farm environments.

9Biology and Biotechnology Communications. MOLECULAR EPIDEMIOLOGY AND PHYLOGENETIC TRACKING OF MULTIDRUG-RESISTANT SALMONELLA STRAINS IN INTEGRATED LIVESTOCK PRODUCTION SYSTEMS

The problem extends beyond farm animals. A study of synanthropic small mammals (rats and shrews living near humans) in Bangladesh found that nearly 40% carried multidrug-resistant Salmonella. Shrews had almost four times the odds of carrying resistant strains compared to rodents, and animals trapped in and around human dwellings had significantly higher carriage rates than those caught on agricultural land.

10PubMed Central. Ecology and epidemiology of multidrug-resistant Salmonella in synanthropic small mammals in Bangladesh

For typhoidal Salmonella, the resistance trend is equally alarming. Extensively drug-resistant typhoid strains, susceptible to only one or two remaining antibiotic classes, have already caused large outbreaks in Pakistan and parts of Africa. The organism that Theobald Smith first cultured in the 1880s is proving remarkably adept at evolving around the drugs designed to kill it.

An Ancient Lineage with a Recent Name

While Salmonella entered the scientific record in the 1880s, the organism itself is far older. Molecular clock analyses estimate that Salmonella and its closest relative, Escherichia coli, diverged roughly 100 to 160 million years ago, placing their split in the same general time frame as the diversification of placental mammals during the age of dinosaurs.

11PubMed Central. Expression Divergence between Escherichia coli and Salmonella enterica serovar Typhimurium Reflects Their Lifestyles

That deep evolutionary history helps explain why Salmonella is so versatile. Over tens of millions of years, different lineages adapted to different ecological niches: some became gut commensals of reptiles, some specialized in birds, some found their way into mammals, and a few narrowed their focus to a single host species. Salmonella Typhi’s restriction to humans is probably a relatively recent evolutionary event, but it sits atop a lineage that has been exploring new hosts for an almost incomprehensible span of time.

Theobald Smith could not have known any of this when he peered through his microscope at cultures from sick pigs. What he saw was a rod-shaped bacterium that grew on standard media and killed laboratory animals. What he had actually found was a single thread in a tapestry of microbial diversity stretching back to the Cretaceous. And what he got for it was a footnote, while his boss got the genus name. Science has, at least, corrected the record in the decades since, even if the nomenclature has not caught up.